These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2465211)

  • 1. New diagnostic possibilities for the detection of thrombophilic states.
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):253-9. PubMed ID: 2465211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of thrombin-antithrombin complexes in hypercoagulability conditions. Analysis of 182 cases].
    Zuazu-Jausoro I; Borrell M; Urrutia T; Oliver A; Montserrat I; Mateo J; Ribera L; Fontcuberta J
    Sangre (Barc); 1990 Oct; 35(5):375-9. PubMed ID: 2291147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin cofactor II studies in thrombophilic patients].
    Pál A; Sas G
    Orv Hetil; 1990 Mar; 131(9):461-2, 465. PubMed ID: 2179813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in patients with known risk factors for thromboembolism.
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):927-34. PubMed ID: 2483712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of hypercoagulability].
    Vinazzer H
    Wien Klin Wochenschr; 1984 Dec; 96(24):872-5. PubMed ID: 6528615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis.
    Levy PJ; Gonzalez FM; Rush DS; Haynes JL
    J Am Coll Surg; 1994 Mar; 178(3):266-70. PubMed ID: 8149019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of newly developed technology in blood coagulation disorders].
    Matsuo T
    Rinsho Byori; 2002 May; 50(5):506-12. PubMed ID: 12078050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of coagulation disorders].
    Esnaola-Rojas MM
    Rev Neurol; 1999 Dec 16-31; 29(12):1290-300. PubMed ID: 10652759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-thrombin III levels in some Malaysian patients suspected of having acquired coagulation disorders.
    Tan SH; Doraisamy G; Noriah R; Lopez CG
    Singapore Med J; 1983 Feb; 24(1):33-6. PubMed ID: 6867763
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antithrombin III control in patients with long-term anticoagulant therapy].
    Hönig JF; Merten HA; Korth O; Halling F; Köstering H
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):330-3. PubMed ID: 1840095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombogenic thrombopenia related to heparin. Clinical, biological and therapeutic results. Apropos of 32 cases].
    Laprevote-Heully MC; Bollaert PE; Bauer P; Briquel ME; Alexandre P; Lambert H; Larcan A
    J Mal Vasc; 1987; 12 Suppl B():133-7. PubMed ID: 2834485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins.
    High KA
    Arch Pathol Lab Med; 1988 Jan; 112(1):28-36. PubMed ID: 2962557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are screening tests necessary for detection of hypercoagulability states in situations of risk of thromboembolic episodes?].
    García de Tena J; de Miguel Díez J; Serrano Iglesias JA
    Med Clin (Barc); 1997 Feb; 108(5):197. PubMed ID: 9091725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.